Lantus Dosing Frequency
Lantus (insulin glargine) is administered once daily at the same time each day 1.
Standard Dosing Schedule
The FDA-approved labeling is explicit: Lantus should be administered subcutaneously once a day at the same time every day 1. The medication may be given at any time during the day—morning, evening, or bedtime—but consistency in timing is essential for maintaining stable basal insulin coverage.
Pharmacologic Rationale
Lantus exhibits a relatively constant glucose-lowering profile over 24 hours that permits once-daily dosing 1. The medication slowly releases insulin over 24 hours with no pronounced peak action time, creating physiologic basal insulin levels 2. This peakless profile distinguishes it from intermediate-acting insulins like NPH that require twice-daily administration.
Clinical Context by Diabetes Type
For Type 1 Diabetes:
- Lantus is used once daily as basal insulin (typically 16-24 units or approximately one-third of total daily insulin requirements) 2, 1
- Must be combined with rapid-acting insulin at mealtimes 3, 4
- The once-daily basal dose provides stable glucose control between meals and overnight 2
For Type 2 Diabetes:
- Initial dose is 10 units (or 0.2 units/kg) once daily 1
- Titrated based on fasting blood glucose targets 5
- Often the first insulin introduced in type 2 diabetes management 6
Exception: Twice-Daily Dosing
While once-daily dosing is standard, some patients may require twice-daily administration in specific circumstances 3, 4:
- Insulin detemir or certain glargine formulations may require twice-daily dosing when once-daily administration fails to provide 24-hour coverage 3, 4
- Labile type 1 diabetes patients may benefit from split dosing 6
- Obese, insulin-resistant patients requiring high volumes may need divided doses 6
- Patients experiencing morning hypoglycemia despite dose titration 7
However, this represents a deviation from standard practice and should only occur under medical supervision with appropriate glucose monitoring 1.
Critical Administration Details
- Same time daily: Consistency in administration timing is mandatory 1
- Subcutaneous only: Never administer intravenously or via insulin pump 1
- Rotate injection sites: Within the same region (abdomen, thigh, or deltoid) to reduce lipodystrophy risk 1
- Do not mix: Cannot be mixed with other insulins in the same syringe 6
Common Pitfall
The most frequent error is inconsistent timing of the daily dose. While Lantus can be given at any time of day, changing the administration time without medical supervision can lead to gaps or overlaps in insulin coverage, potentially causing hyperglycemia or hypoglycemia 1.